Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

FMC Science LLC

Neither a doctor nor a teaching hospital

Research payments

$2,721,473

821 payments

Through program year 2024, FMC Science LLC is reported as receiving $2,721,473 in research payments, across 821 payments.

By program year

6 rows
Year Kind Amount Payments
2024 Research $4,400 2
2023 Research $132,981 49
2022 Research $552,513 218
2021 Research $800,351 249
2020 Research $608,885 133
2019 Research $622,344 170

Breakdown

Who paid Research payments · program years 2019–2024
  1. AbbVie, Inc. $1,105,326 330 payments
  2. GlaxoSmithKline, LLC. $698,860 324 payments
  3. Pfizer Inc. $589,046 101 payments
  4. AstraZeneca Pharmaceuticals LP $155,131 8 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $82,521 42 payments
  6. Biohaven Pharmaceuticals, Inc. $52,082 8 payments
  7. Merck Sharp & Dohme Corporation $23,632 3 payments
  8. AstraZeneca UK Limited $12,230 3 payments
  9. Lexicon Pharmaceuticals, Inc. $2,645 2 payments
Studies the money was for Research payments · program years 2019–2024
  1. A Phase 3 Randomized Doubleblinded Placebocontrolled Trial to Evaluate the Efficacy and Safety of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy $589,046 101 payments
  2. M16-283 $406,611 110 payments
  3. A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Countr $369,973 200 payments
  4. Study name not reported $287,775 108 payments
  5. M16-100 $205,775 41 payments
  6. 24-Hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Receiving Testosterone Replacement Therapy $120,463 41 payments
  7. A Phase 2b Multicenter Randomised Double blind Placebo controlled Study of Verinurad and Allopurinol in Patients with Chronic Kidney Disease and Hyperuricemia $113,353 2 payments
  8. M19-161 $99,548 31 payments
  9. Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study $95,679 26 payments
  10. BAY1002670 Long term Safety vs SoC $67,710 29 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record